ASCL2 and neoplasm: Compared with the ApcMin/+;Ascl2 CKO mice, ApcMin/+ mice displayed more activated CAFs and reduced tumor-infiltrating CD8+ T cells, leading to a tumor suppressive immune microenvironment (Fig. 6A).